Sigma Planning Corp Has $4.38 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sigma Planning Corp cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,387 shares of the medical equipment provider’s stock after selling 161 shares during the quarter. Sigma Planning Corp’s holdings in Intuitive Surgical were worth $4,378,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Bennett Selby Investments LP grew its stake in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares during the period. LVW Advisors LLC boosted its stake in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. boosted its stake in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares during the period. Journey Strategic Wealth LLC boosted its stake in Intuitive Surgical by 1.9% in the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC boosted its stake in Intuitive Surgical by 3.7% in the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after purchasing an additional 19 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 2.4 %

Shares of NASDAQ ISRG opened at $591.79 on Friday. The stock has a market cap of $210.78 billion, a price-to-earnings ratio of 92.32, a P/E/G ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock’s 50-day moving average is $565.45 and its 200 day moving average is $525.06.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 6,348 shares of company stock valued at $3,587,582. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of several analyst reports. Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Leerink Partners raised their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, Truist Financial lifted their price target on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.